Showing 2161-2170 of 5771 results for "".
- Envision Announces New Collaborative Research Agreement With Wichita State Universityhttps://modernod.com/news/envision-announces-new-collaborative-research-agreement-with-wichita-state-university/2477361/Envision and Wichita State University announced that they have entered into a Collaborative Research Agreement that will guide joint projects geared toward improving the quality of life of individuals who are blind or visually impaired. The agreement covers initiatives and programs related to res
- PRISM Vision Group Announces Agreement With The Retina Group of Washingtonhttps://modernod.com/news/prism-vision-group-announces-agreement-with-the-retina-group-of-washington-2/2477356/PRISM Vision Group announced an agreement to add its newest partner, The Retina Group of Washington (RGW), a provider of retinal and macular care in Washington, D.C., Virginia and Maryland. Terms of the deal were not disclosed. “Medicine is changing around us and over the past sever
- CooperVision Announces Availability of Biofinity Toric Multifocal Contact Lenseshttps://modernod.com/news/coopervision-announces-availability-of-biofinity-toric-multifocal-contact-lenses/2477352/To enable eye care professionals to address their astigmatic patients’ evolving presbyopic needs, CooperVision has announced the availability of its new Biofinity toric multifocal contact lenses. The company has begun initial shipments of the lenses, with nationwide availability expected in May.<
- Prism Vision Group Announces Agreement With the Retina Group of Washingtonhttps://modernod.com/news/prism-vision-group-announces-agreement-with-the-retina-group-of-washington/2477344/Integrated eyecare services organization PRISM Vision Group announced an agreement to add The Retina Group of Washington (RGW), which provides retinal and macular care in Washington D.C., Virginia and Maryland. Terms of the deal were not disclosed. “Medicine is changing around us an
- Vision Expo East Announces Speakers and Experiences for The Bridge and Innovation Stagehttps://modernod.com/news/vision-expo-east-announces-speakers-and-experiences-for-the-bridge-and-innovation-stage/2477341/Vision Expo announced the series of events and speakers planned for The Bridge and Innovation Stage at the 2020 event in New York City. In keeping with Vision Expo’s renewed focus on discovery, experience, and connection, attendees can expect a robust lineup of industry experts, creative luminari
- ImprimisRx Announces Supply Agreement with Vision Center Network of America (VCNA)https://modernod.com/news/imprimisrx-announces-supply-agreement-with-vision-center-network-of-america-vcna/2477342/ImprimisRx announced that it has agreed to a product supply agreement with Vision Center Network of America LLC (VCNA). The agreement will make ImprimisRx a VCNA preferred provider for a variety of surgical formulations, including a portfolio of topical and injectable products. Terms of t
- EyePoint Pharmaceuticals Announces Positive Topline 36-Month Follow-up Data for Second Phase 3 Study of Yutiqhttps://modernod.com/news/eyepoint-pharmaceuticals-announces-positive-topline-36-month-follow-up-data-for-second-phase-3-study-of-yutiq/2477336/EyePoint Pharmaceuticals announced positive topline 36-month follow-up data from the second phase 3 trial of Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye. “The d
- Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meetinghttps://modernod.com/news/allergan-to-present-new-data-for-investigational-bimatoprost-sustained-release-at-american-glaucoma-society-annual-meeting/2477323/Allergan will present new data from investigational Bimatoprost sustained-release (SR) at the annual meeting of the American Glaucoma Society (AGS) to be held in Washington, DC. Data from the phase 3 ARTEMIS studies will be presented during an oral session and wil
- ReNeuron Announces Positive Long-Term Data in Retinitis Pigmentosa Trialhttps://modernod.com/news/reneuron-announces-positive-long-term-data-in-retinitis-pigmentosa-trial/2477320/ReNeuron Group has announced positive long-term data from the ongoing phase 1/2a clinical trial of its hRPC stem cell therapy candidate in retinitis pigmentosa (RP) and plans to expand the ongoing study. In October 2019, positive interim efficacy data from p
- Allergan, Sightsavers, and the IAPB Announce the “Keep Sight” Initiative to Address Glaucoma in Ganjam, Odishahttps://modernod.com/news/allergan-sightsavers-and-the-iapb-announce-the-keep-sight-initiative-to-address-glaucoma-in-ganjam-odisha/2477318/Allergan, Sightsavers, and the International Agency for the Prevention of Blindness (IAPB) announced the launch of its unique joint initiative, ‘Keep Sight India,’ a community-based glaucoma screening program to prevent glaucoma-related vision loss in Ganjam District, Odisha. The pilot kicked off